Skip to content

ASSENTFARMA: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

ASSENTFARMA

BE 0476.449.350
NACE 47.730, Retail sale of pharmaceutical products
financial year 2024 compared with 2023filed annual accounts (NBB)
Net result for the year
€136,937
2023 · €116,630+€20,307
Equity
€831,368
2023 · €754,431+€76,937
Cash
€357,650
2023 · €460,245-€102,595
Balance sheet total
€1.1m
2023 · €983,938+€97,806

Largest movements

2023 to 2024
Assets
  • Current investments +€250,000

    new in 2024: €250,000

  • Cash -€102,595

    down €102,595 (-22.3%), from €460,245 to €357,650

    mainly Current investments (-€250,000) and Contributions, distributions and other (-€60,000)

  • Receivables within one year -€50,439

    down €50,439 (-15.4%), from €326,944 to €276,504

    of which Other amounts receivable: -€50,589

Equity and liabilities
  • Profit (loss) carried forward +€76,937

    up €76,937 (+14.1%), from €546,621 to €623,558

  • Other debts +€13,423

    up €13,423 (+9.1%), from €148,169 to €161,592

Income statement
  • Gross operating margin +€27,020

    up €27,020 (+15.9%), from €169,657 to €196,677

  • Financial income +€3,438

    up €3,438 (+127%), from €2,716 to €6,155

    of which Non-recurring financial income: +€2,053

  • Staff costs +€3,287

    up €3,287 (+30.4%), from €10,796 to €14,083

  • Taxes +€2,627

    up €2,627 (+10.5%), from €24,906 to €27,533

  • Financial charges +€2,623

    up €2,623 (+32.7%), from €8,023 to €10,646

From the 2023 result to the 2024 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2023 €116,630
Gross operating margin +€27,020
Staff costs -€3,287
Depreciation -€1,607
Other operating charges -€7
Financial income +€3,438
Financial charges -€2,623
Taxes -€2,627
Result 2024 €136,937
raises the resultlowers the result

Derived cash bridge

cash 2023 to 2024

Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€219,612
Investment -€262,206
Financing -€60,000
Cash 2023 €460,245
Net result for the year +€136,937
Depreciation +€12,665
Stocks and contracts -€762
Receivables within one year +€50,439
Deferred charges and accrued income -€537
Trade debts +€5,094
Tax, wage and social debts +€777
Other debts +€13,423
Accrued charges and deferred income +€1,575
Investment in fixed assets (net) -€12,206
Current investments -€250,000
Contributions, distributions and other -€60,000
Cash 2024 €357,650
brings cash intakes cash out
Every line side by side 47 lines
Line Code 2023 2024 Change %
Total assets 20/58 €983,938 €1,081,745 +€97,806 +9.9%
Fixed assets 21/28 €50,134 €49,675 -€459 -0.9%
Tangible fixed assets 22/27 €50,134 €49,675 -€459 -0.9%
Plant, machinery and equipment 23 €47,647 €48,727 +€1,080 +2.3%
Furniture and vehicles 24 €2,487 €948 -€1,539 -61.9%
Current assets 29/58 €933,805 €1,032,070 +€98,265 +10.5%
Stocks and contracts in progress 3 €133,993 €134,755 +€762 +0.6%
Stocks 30/36 €133,993 €134,755 +€762 +0.6%
Amounts receivable within one year 40/41 €326,944 €276,504 -€50,439 -15.4%
Trade receivables 40 €136,615 €136,765 +€150 +0.1%
Other amounts receivable 41 €190,329 €139,740 -€50,589 -26.6%
Current investments 50/53 - €250,000 +€250,000
Cash at bank and in hand 54/58 €460,245 €357,650 -€102,595 -22.3%
Deferred charges and accrued income 490/1 €12,623 €13,160 +€537 +4.3%
Total equity and liabilities 10/49 €983,938 €1,081,745 +€97,806 +9.9%
Equity 10/15 €754,431 €831,368 +€76,937 +10.2%
Contributions 10/11 €62,000 €62,000 = 0.0%
Capital 10 €62,000 €62,000 = 0.0%
Issued capital 100 €62,000 €62,000 = 0.0%
Reserves 13 €145,810 €145,810 = 0.0%
Non-distributable reserves 130/1 €6,200 €6,200 = 0.0%
Legal reserve 130 €6,200 €6,200 = 0.0%
Distributable reserves 133 €139,610 €139,610 = 0.0%
Profit (loss) carried forward 14 €546,621 €623,558 +€76,937 +14.1%
Amounts payable 17/49 €229,507 €250,377 +€20,869 +9.1%
Amounts payable within one year 42/48 €223,228 €242,523 +€19,294 +8.6%
Trade debts 44 €71,553 €76,646 +€5,094 +7.1%
Suppliers 440/4 €71,553 €76,646 +€5,094 +7.1%
Taxes, remuneration and social security 45 €3,507 €4,284 +€777 +22.2%
Taxes 450/3 €3,507 €4,284 +€777 +22.2%
Other amounts payable 47/48 €148,169 €161,592 +€13,423 +9.1%
Accrued charges and deferred income 492/3 €6,279 €7,854 +€1,575 +25.1%
Non-recurring operating income 76A €293 €242 -€51 -17.4%
Remuneration, social security and pensions 62 €10,796 €14,083 +€3,287 +30.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €11,058 €12,665 +€1,607 +14.5%
Other operating charges 640/8 €960 €968 +€7 +0.8%
Gross operating margin 9900 €169,657 €196,677 +€27,020 +15.9%
Operating profit (loss) 9901 €146,844 €168,962 +€22,118 +15.1%
Financial income 75/76B €2,716 €6,155 +€3,438 +127%
Recurring financial income 75 €2,662 €4,048 +€1,385 +52.0%
Non-recurring financial income 76B €54 €2,107 +€2,053 +3,802%
Financial charges 65/66B €8,023 €10,646 +€2,623 +32.7%
Recurring financial charges 65 €8,023 €10,646 +€2,623 +32.7%
Profit (loss) for the period before taxes 9903 €141,537 €164,470 +€22,934 +16.2%
Income taxes 67/77 €24,906 €27,533 +€2,627 +10.5%
Profit (loss) for the period 9904 €116,630 €136,937 +€20,307 +17.4%
Profit (loss) for the period to be appropriated 9905 €116,630 €136,937 +€20,307 +17.4%

Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.